Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 12, 2011, Pages 3341-3345

  Wu, Han Lin ^a,b   Tian, Qian ^a   Peng, Chun Wei ^a   Liu, Shao Ping ^a   Li, Yan ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Jinmen First People's Hospital   (China)

Author keywords

China; Clinico pathological factors; Gastric cancer; Multivariate analysis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CHINA; CLINICAL TRIAL; COLLOID CARCINOMA; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHINA; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84864521261     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Adachi Y, Yasuda K, Inomata M, et al (2000). Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer, 89, 1418-24
2. Bruno L, Nesi G, Nobili S, et al (2008). Postoperative chemotherapy in resected gastric cancer: results of a single center experience. J Chemother, 20, 497-502
3. Chen WQ, Zhang SW, Zheng RS, et al (2011). A report of cancer incidence and mortality from 38 cancer registries in China, 2007. China Cancer, 20, 162-9 (in Chinese).
4. China Health Statistics Year Book (2010). http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/index2010.html. Accessed 20 June 2011.
5. Cunningham D, Allum WH, Stenning SP, et al (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 355, 11-20
6. Deng J, Liang H, Wang D, et al (2011). Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today, 41, 210-5
7. Hartgrink HH, van de Velde CJ, Putter H, et al (2004). Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol, 30, 643-9
8. Hochwald SN, Kim S, Klimstra DS, Brennan MF, Karpeh MS (2000). Analysis of 154 actual five-year survivors of gastric cancer. J Gastrointest Surg, 4, 520-5
9. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90
10. Li JW, Liang H, Wang XN (2006). The analysis of prognostic factors for 814 patients with gastric cancer. Chin J Clin Oncol, 22, 399-402 (in Chinese).
11. Macdonald JS, Smalley SR, Benedetti J, et al (2001). Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 345, 725-30
12. Peng CW, Li Y, Yang GL, et al (2010). Postoperative recurrence in gastric cancer: analysis of 59 cases. Hepato-gastroenterology, 57, 663-7
13. Sakuramoto S, Sasako M, Yamaguchi T, et al (2007). Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med, 357, 1810-20
14. Shiraishi N, Inomata M, Osawa N, et al (2000). Early and late recurrence after gastrectomy for gastric carcinoma: univariate and multivariate analyses. Cancer, 89, 255-61
15. Wang W, Sun XW, Li CF, et al (2011). Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1, 503 patients. Ann Surg Oncol, 18, 1060-7
16. Washington K (2010). 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol, 17, 3077-9
17. WHO (2011) Definition of an older or elderly person. http://www.who.int/healthinfo/survey/ ageingdefnolder/en/ Accessed 20 June 2011.
18. Wu AW, Ji JF, Yang H, Li YN, Li SX (2010). Long-term outcome of a large series of gastric cancer patients in China. Chin J Cancer Res, 22, 167-75.
19. Yang XJ, Huang CQ, Suo T, et al (2011). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol, 18, 1575-81
20. Zhao G, Qiu JF, Wu ZY (2007). Prognostic factor analysis of 603 cases with gastric cancer undergoing radical resection. China Oncol, 17, 556-9 (in Chinese).
21. Zhang XF, Huang CM, Lu HS, et al (2002). Clinical study on the surgical treatment and outcome in gastric cancer. Natl Med J China, 82, 1142-3 (in Chinese).